Systematic Reviews
Copyright ©The Author(s) 2016.
World J Meta-Anal. Apr 26, 2016; 4(2): 10-43
Published online Apr 26, 2016. doi: 10.13105/wjma.v4.i2.10
Table 1 Selected details of the 102 studies in publication date order
Study refMain refOther refLocationStudy design1Study dates2Total casesNever smoker criteria3
GARFI1[75][104]United StatesP1959 -1960,1971153Dur 6 mo
CHAN[105][106,107]Hong KongCC1976 -197784
CORREA[67]United StatesCC1979 -198232
TRICHO[27][108,109]GreeceCC1978 -198277
BUFFLE[110]United StatesCC1976 -198052
HIRAYA[28][111-120]JapanP1965 -1966,1981264
KABAT1[53]United StatesCC1971 -198076
GARFI2[121][122]United StatesCC1971 -1981134
LAMW[29]Hong KongCC1981 -198475
WU[123]United StatesCC1981 -198231
AKIBA[68]JapanCC1971 -1980113
LEE[124]United KingdomCC1979 -198247
BROWN1[125]United StatesCC1979 -198219
GAO[126]ChinaCC1984 -1986246
HUMBL1[127]United StatesCC1980 -198428Dur 6 mo
KOO[128][129-133]Hong KongCC1981 -198388N20
LAMT[30]Hong KongCC1983 -1986199Occ (1 yr)
PERSHA[134][135]SwedenCC1961 -198077
BUTLER[136]United StatesP1976 -1976,19828
GENG[31][137]ChinaCC1983 -198354
INOUE[138]JapanCC1973 -198328
SHIMIZ[70]JapanCC1982 -198590
CHOI[139]South KoreaCC1985 -198888
HOLE[140][141]ScotlandP1972 -1976,19859
SCHOEN[142]United StatesCC1982 -1983116
SVENSS[143][144]SwedenCC1983 -198534Occ
JANERI[72][145]United StatesCC1982 -1985191N100
KALAND[32]GreeceCC1987 -198991
SOBUE[146][147]JapanCC1986 -1988144
WU-WIL[46]ChinaCC1985 -1987417
LIUZ[148][149,150]ChinaCC1985 -1986541sm
BROWN2[151][152-155]United StatesCC1986 -1991432
STOCKW[58][156]United StatesCC1987 -1991210N100, Dur 6 mo
DU[52][157-159]ChinaCC1986 -198675
LIUQ[160]ChinaCC1983 -198438
FONTHA[33][161-164]United StatesCC1986 -1988653N100, Dur 6 mo
LAYARD[165]United StatesCC1986 -198660
DEWAAR[166][167]NetherlandsCC1977 -199123Cot
KABAT2[168][169,170]United StatesCC1983 -1990110
SCHWAR[57]United StatesCC1984 -1987257
SUN[60]ChinaCCNA230
WANGS[34]ChinaCCNA82
WANGT[171]ChinaCC1992 -1994135
CARDEN[73][172,173]United StatesP1982 -1982,1989362
ZHENG[35]ChinaCC1990 -199394Non
AUVINE[174]FinlandCC1986 -199244
BOFFET[66][175-180]West EuropeCC1988 -1994640N400
SHEN[181][182-185]ChinaCC1993 -199370
ZARIDZ[36][186-188]RussiaCC1991 -1993189
BOFFE2[189]EuropeCC1994 -199670N400
JEE[190]South KoreaP1992 -1994,199779Occ, Dur 1 yr
RAPITI[61]IndiaCC1991 -199258N400
SPEIZE[191]United StatesP1982 -1982,199235
ZHONG[54]ChinaCC1992 -1994504Dur 6 mo
LEECH[37][192-194]TaiwanCC1992 -1998268N400
MALATS[195][196]Europe/BrazilCCNA122Occ
WANGL[62][197]ChinaCC1994 -1998233Dur 6 mo
JOHNSO[198][199-201]CanadaCC1994 -199771N100
LAGARD[202][203]SwedenCC1980 -1995433Occ (1 yr)
NISHIN[204]JapanP1984 -1984,199224
OHNO[205]JapanCCNA191N365
RACHTA[63][206]PolandCC1991 -199754Dur 6 mo
ENSTRO[207][208]United StatesP1959 -1960,1998256
ZATLOU[64][209,210]Czech RepublicCC1998 -200284N100
IARCKR[1][180]GermanyCC1990 -1996123Dur 6 mo, N400
MCGHEE[211]Hong KongCC1998 -1998324
EPICA[212][213-216]Western EuropeP1993 -1998,200059
FANG[38][216]ChinaCC2001 -2004157
FRANCO[71][216]MexicoCC2000 -200294
GORLOV[55][217-222]United StatesCC1995 -2003193N100
NEUBER[49]United StatesCC1994 -199756N100, Dur 6 mo
RYLAND[223]SwedenCC1989 -199449
WEN[56][224-227]ChinaP1997 -2000,2004106
YU[228][228-230]Hong KongCC2002 -2004213N400, Dur 1 yr
ZEKA[59]East Europe, United KingdomCC1998 -2002223N100
HILL1[231]New ZealandP1981 -1981,1984147Occ
HILL2[231]New ZealandP1996 -1996,1999234Occ
LOPEZC[232]SpainCC2000 -200536N100
ASOMAN[233]United StatesCC1992 -NA138Occ (1 yr)
GALLEG[51]MexicoCC2003 -200732
KURAHA[234]JapanP1990 -1993,2004109
PANDEY[50]NepalCCNA268
YANG[39][65,221,235,236]United StatesCC1997 -2008297N100
OLIVOM[65][237]United StatesCCNA45N100
TSE[238][239]ChinaCC2004 -2006132N400, Dur 1 yr
LIANG[40]ChinaCC2004 -2007226
BRENNE[47]CanadaCC1997 -2002156N100
JIANG[41]ChinaCC2009 -2009145
EPICC[240][212]Western EuropeP1992 -1998,200698
KIYOHA[241]JapanCC1996 -2008153
HE[242][243]ChinaP1976 -1994,201116N100
LIM[74][244-246]ChinaCC1996 -2008433Occ (1 yr)
LIN[42]ChinaCC2006 -2010226
FERREC[247]ChileCC2007 -201059
ALZOUG[48][248,249]CanadaCC1996 -200044N100
GELAC[43]TaiwanCC2002 -20091540Occ
MASJED[44][250]IranCC2002 -200581Dur 6 mo
REN[251]ChinaCC2002 -2012764
SEKI[252]JapanCC1997 -2009431
WHIOS[253][254]United StatesP1993 -1998,2009200
ILCCO[45][69]InternationalCC1984 -20142504N100
TORRES[255][256]SpainCC2011 -2013192N100
Table 2 Further details of the 102 studies
Ref.ETS exposures1Adjustment variables used2Extent (%) of histological confirmationResults by histological typeDose-response results available3
GARFI1s7NAYes
CHANs080
CORREAs c4197Yes
TRICHOs027YesYes
BUFFLEh0100Yes
HIRAYAs2NAYes
KABAT1s h w4100
GARFI2s h w c o tot4100YesYes
LAMWs tot1100Yes
WUs w c tot42100Yes
AKIBAs c653Yes
LEEs h w tr o tot338Yes
BROWN1tot3100Yes
GAOs h c tot243Yes
HUMBL1s2100Yes
KOOs h w c tot597YesYes
LAMTs0100YesYes
PERSHAs c283YesYes
BUTLERs2100
GENGs085Yes
INOUEs3NAYes
SHIMIZs h w3100
CHOIs0100Yes
HOLEh2NAYes
SCHOENs6100
SVENSSh c tot170
JANERIs h w c o3100YesYes
KALANDs h w548YesYes
SOBUEs h c3100
WU-WILs h w c542
LIUZh317
BROWN2s h w c276YesYes
STOCKWs h w4 c o4 tot3100YesYes
DUs2NAYes
LIUQs332Yes
FONTHAs h w c o tot10100YesYes
LAYARDs3NAYes
DEWAARtot071Yes
KABAT2s h w c tr o tot6100Yes
SCHWARh w2100
SUNs h w c hw tot2100Yes
WANGStot0100
WANGTs w c157Yes
CARDENs h w o tot8NAYes
ZHENGh282YesYes
AUVINEtot1NA
BOFFETs h w c tr o tot796YesYes
SHENtot9100YesYes
ZARIDZs h w c2100YesYes
BOFFE2s w c tot5100YesYes
JEEs50Yes
RAPITIs w c tr3100YesYes
SPEIZEtot1100
ZHONGs h w c tot757YesYes
LEECHs h w c tot7100Yes
MALATSs tot2100Yes
WANGLh c632Yes
JOHNSOh w c tot4100Yes
LAGARDh tot6100
NISHINs h7NA
OHNOs w c tr o tot2100Yes
RACHTAc21100Yes
ENSTROs8NA
ZATLOUc tot3100Yes
IARCKRs w c2100Yes
MCGHEEh20Yes
EPICAh w tot7NA
FANGtot8100Yes
FRANCOh2100
GORLOVh w hw tot4100
NEUBERtot43100
RYLANDh w398
WENs w c tot9NAYes
YUtot20100Yes
ZEKAw4NAYes
HILL1h9NA
HILL2h9NA
LOPEZCtot0100
ASOMANh w o0100
GALLEGtot0100
KURAHAs w c hw tot590YesYes
PANDEYc tot0NAYes
YANGc tot5NA
OLIVOMc4100Yes
TSEh w tot9100YesYes
LIANGc tot0100
BRENNEh w c tot3100Yes
JIANGtot17100Yes
EPICCc10NAYes
KIYOHAs0100
HEtot988Yes
LIMh096
LINtot9100Yes
FERRECc tot4372
ALZOUGs h w c tot3NAYesYes
GELACs h w hw tot6100Yes
MASJEDs h w o tot4100Yes
RENtot5100
SEKIs794Yes
WHIOSh4 w4 c4 tot004
ILCCOh w c tot3100YesYes
TORRESh299Yes
Table 3 Meta-analyses of smoking by the spouse (or nearest equivalent)
Estimates consideredNo. of estimatesRelative risk (95% confidence limits)
Heterogeneity1
Fixed-effects meta-analysisRandom-effects meta-analysis
All1191.18 (1.14-1.23)1.21 (1.14-1.29)+++
N America381.08 (1.00-1.17)1.09 (0.95-1.26)+++
Europe221.15 (1.03-1.28)1.16 (1.00-1.35)(+)
Asia541.24 (1.17-1.32)1.31 (1.20-1.44)+++
Asia - Japan131.26 (1.11-1.45)1.26 (1.11-1.45)NS
Asia - Hong Kong81.32 (1.12-1.57)1.31 (1.06-1.63)NS
Asia - China231.16 (1.06-1.27)1.29 (1.08-1.54)+++
Asia - Other101.34 (1.19-1.51)1.37 (1.19-1.57)NS
Heterogeneity between Asian countriesNS
Other continents51.20 (1.09-1.33)1.20 (1.09-1.33)NS
Heterogeneity between continents(+)
Published in 1981-1989341.38 (1.24-1.54)1.38 (1.24-1.54)NS
Published in 1990-1999331.09 (1.01-1.17)1.15 (1.02-1.28)++
Published in 2000-2009341.22 (1.12-1.33)1.21 (1.08-1.36)+
Published in 2010 onwards181.17 (1.10-1.26)1.13 (0.94-1.36)+++
Heterogeneity by publication date++
1-49 cases231.44 (1.14-1.81)1.47 (1.15-1.88)NS
50-99311.30 (1.14-1.47)1.27 (1.08-1.50)+
100-199291.09 (1.00-1.19)1.10 (0.96-1.26)+++
200-399221.33 (1.21-1.46)1.32 (1.16-1.50)+
400+141.14 (1.07-1.20)1.13 (1.02-1.25)++
Heterogeneity by study size++
Case-control971.18 (1.13-1.23)1.22 (1.13-1.31)+++
Prospective221.18 (1.05-1.33)1.18 (1.05-1.33)NS
Heterogeneity by study typeNS
Not age adjusted211.34 (1.19-1.50)1.42 (1.18-1.71)+
Age adjusted981.16 (1.11-1.21)1.18 (1.10-1.26)+++
Heterogeneity by age adjustmentNS
Dose-response results not reported461.13 (1.06-1.21)1.18 (1.06-1.31)++
Only no dose-response stated20.95 (0.60-1.50)0.95 (0.60-1.50)NS
Dose-response results reported711.21 (1.15-1.28)1.24 (1.14-1.35)+++
Heterogeneity by dose response reportingNS
Spouse the index711.18 (1.11-1.24)1.21 (1.12-1.31)++
Spouse not the index481.19 (1.12-1.27)1.20 (1.07-1.35)+++
Heterogeneity by index definitionNS
Table 4 Meta-analyses of childhood environmental tobacco smoke exposure
Estimates consideredNo. of estimatesRelative risk (95% confidence limits)
Heterogeneity1
Fixed-effects meta-analysisRandom-effects meta-analysis
From any cohabitant411.08 (1.01-1.15)1.15 (1.02-1.29)+++
N America131.00 (0.89-1.13)1.06 (0.89-1.28)+
Europe110.94 (0.81-1.08)1.02 (0.81-1.29)+
Asia151.26 (1.11-1.42)1.31 (1.02-1.67)+++
Other21.10 (0.95-1.28)1.13 (0.89-1.45)NS
Heterogeneity between continents+
From mother specifically90.96 (0.77-1.20)0.98 (0.77-1.25)NS
From father specifically110.90 (0.80-1.00)1.00 (0.78-1.29)+++
From parents specifically80.78 (0.64-0.94)0.78 (0.64-0.94)NS
Table 5 Estimates used when adjusting for potential confounding effects1
StatisticFruit consumptionVegetable consumptionDietary fat consumptionEducation
Lung cancer riskN studies1416612
RR20.860.881.220.91
(95%CI)(0.78-0.96)8(0.80-0.97)8(1.09-1.36)8(0.88-0.95)6
perSDSDSDYear3
ETS exposureN studies11161213
at homeDifference24-0.0737-0.05680.1317-0.5346
(SE)-0.02-0.021-0.032-0.063
unitSDSDSDYear3
Correlations5Fruit consumption1+0.3147-0.104NS+0.143NS
Vegetable consumption1-0.054NS-0.1309
Dietary fat consumption1-0.039NS
Education1
Table 6 Adjusted/corrected analyses: Husband smoking1
StudiesnUnadjusted for confoundingUncorrected for misclassificationRR (95%CI)Adjusted for confounding2Uncorrected for misclassificationRR (95%CI)Adjusted for confounding2Corrected for misclassification3RR (95%CI)
All931.219 (1.138-1.305)1.139 (1.062-1.221)1.077 (0.999-1.162)
North America291.074 (0.937-1.232)1.004 (0.873-1.154)0.898 (0.775-1.039)
Europe and New Zealand201.174 (1.007-1.369)1.092 (0.934-1.277)1.062 (0.899-1.254)
China (including Hong Kong and study LIM)271.321 (1.144-1.524)1.239 (1.071-1.433)1.175 (1.005-1.374)
Rest of Asia (including study ILCCO)171.284 (1.187-1.389)1.194 (1.103-1.291)1.164 (1.072-1.262)
North America, Europe and New Zealand491.112 (1.004-1.231)1.037 (0.935-1.150)0.959 (0.858-1.072)
Asia441.314 (1.199-1.439)1.229 (1.121-1.348)1.181 (1.070-1.304)
Published in 1980s261.361 (1.216-1.522)1.267 (1.132-1.417)1.194 (1.059-1.347)
Published in 1990s271.152 (1.016-1.305)1.077 (0.948-1.225)1.005 (0.871-1.160)
Published in 2000s261.240 (1.105-1.392)1.163 (1.034-1.308)1.115 (0.987-1.260)
Published in 2010s141.139 (0.945-1.372)1.059 (0.877-1.277)1.026 (0.844-1.247)
< 100 cases491.339 (1.178-1.521)1.249 (1.098-1.422)1.192 (1.038-1.370)
100-199 cases221.117 (0.973-1.284)1.042 (0.904-1.200)0.978 (0.846-1.131)
200-399 cases131.363 (1.190-1.561)1.275 (1.114-1.460)1.226 (1.051-1.429)
400+ cases91.101 (0.973-1.247)1.027 (0.905-1.166)0.957 (0.826-1.108)
With dose-response data4241.308 (1.181-1.449)1.226 (1.105-1.359)1.170 (1.052-1.302)
Without dose-response data691.182 (1.088-1.286)1.104 (1.014-1.201)1.040 (0.948-1.141)
With age adjustment5751.184 (1.100-1.274)1.106 (1.027-1.191)1.048 (0.966-1.136)
Without age adjustment181.437 (1.194-1.728)1.340 (1.110-1.618)1.264 (1.026-1.556)
Case-control studies771.226 (1.133-1.326)1.144 (1.057-1.239)1.080 (0.990-1.177)
Prospective studies161.187 (1.043-1.350)1.111 (0.977-1.264)1.064 (0.928-1.220)
Table 7 Adjusted/corrected analyses: Per 10 cigs smoked by husband1
StudiesnUnadjusted for confoundingUncorrected for misclassificationRR (95%CI)Adjusted for confounding2Uncorrected for misclassificationRR (95%CI)Adjusted for confounding2Corrected for misclassification3RR (95%CI)
All931.102 (1.065-1.140)1.062 (1.027-1.099)1.032 (0.994-1.071)
North America291.037 (0.977-1.101)1.006 (0.946-1.070)0.957 (0.896-1.022)
Europe and New Zealand201.060 (0.995-1.128)1.020 (0.956-1.088)1.003 (0.938-1.073)
China (including Hong Kong and study LIM)271.169 (1.082-1.263)1.127 (1.041-1.219)1.094 (1.006-1.191)
Rest of Asia (including study ILCCO)171.142 (1.095-1.191)1.094 (1.050-1.141)1.079 (1.033-1.127)
North America, Europe and New Zealand491.046 (1.001-1.094)1.012 (0.967-1.059)0.974 (0.928-1.023)
Asia441.158 (1.104-1.216)1.113 (1.060-1.170)1.089 (1.033-1.147)
Published in 1980s261.148 (1.092-1.207)1.105 (1.052-1.162)1.075 (1.019-1.134)
Published in 1990s271.063 (1.004-1.125)1.025 (0.967-1.087)0.988 (0.926-1.053)
Published in 2000s261.123 (1.056-1.194)1.085 (1.020-1.155)1.061 (0.995-1.132)
Published in 2010s141.073 (0.970-1.188)1.032 (0.932-1.143)1.014 (0.912-1.128)
< 100 cases491.143 (1.077-1.213)1.101 (1.036-1.169)1.072 (1.005-1.144)
100-199 cases221.062 (0.993-1.137)1.025 (0.957-1.098)0.994 (0.926-1.066)
200-399 cases131.176 (1.097-1.261)1.134 (1.058-1.216)1.111 (1.027-1.202)
400+ cases91.041 (0.976-1.111)1.002 (0.938-1.070)0.966 (0.895-1.042)
With dose-response data4241.123 (1.072-1.176)1.082 (1.032-1.134)1.053 (1.005-1.103)
Without dose-response data691.091 (1.044-1.139)1.053 (1.007-1.100)1.021 (0.973-1.071)
With age adjustment5751.084 (1.046-1.123)1.044 (1.008-1.082)1.015 (0.976-1.056)
Without age adjustment181.211 (1.101-1.331)1.168 (1.061-1.285)1.131 (1.018-1.256)
Case-control studies771.106 (1.064-1.150)1.066 (1.025-1.109)1.034 (0.991-1.080)
Prospective studies161.081 (1.021-1.145)1.043 (0.985-1.105)1.018 (0.957-1.083)